A case of ramucirumab-related gastrointestinal perforation in gastric cancer with small bowel metastasis

Urakawa, S; Sakai, D; Miyazaki, Y; Kudo, T; Katou, A; Inagaki, C; Tanaka, K; Makino, T; Takahashi, T; Kurokawa, Y; Yamasaki, M; Nakajima, K; Takiguchi, S; Satoh, T; Mori, M; Doki, Y

Sakai, D (reprint author), Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, 2-2,E-2 Yamadaoka, Suita, Osaka 5650871, Japan.; Sakai, D (reprint author), Osaka Univ, Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, E21-19,2-2 Yamadaoka, Suita, Osaka,

SURGICAL CASE REPORTS, 2017; 3 ( ):

Abstract

Background: Ramucirumab is a monoclonal antibody targeting vascular endothelial growth factor receptor 2 (VEGFR-2). Ramucirumab either alone or in com......

Full Text Link